Rapport Therapeutics (RAPP) Change in Acquisitions & Divestments (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $10.1 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $10.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $178.0 million (down 13.53% YoY), and the FY2025 annual result was $167.9 million, down 19.96% from the prior year.
• Change in Acquisitions & Divestments retreated to $10.1 million in Q1 2026 per RAPP's latest filing, from $22.9 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $116.7 million in Q4 2024 and troughed at $3.9 million in Q1 2024.
• A 3-year average of $48.5 million and a median of $38.6 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 209.77% in 2025 and fell as far as 80.37% in 2025.
• A 3-year view of Change in Acquisitions & Divestments shows it stood at $116.7 million in 2024, then slumped by 80.37% to $22.9 million in 2025, then sank by 56.04% to $10.1 million in 2026.
• Business Quant data shows RAPP's Change in Acquisitions & Divestments at $10.1 million in Q1 2026, $22.9 million in Q4 2025, and $45.0 million in Q3 2025.